Subscribe


PD breaking news – Medicines Regulation inquiry calls for comp meds submissions

Questions about efficacy testing, non-compliance deterrents posed. 

The panel conducting the Review of Medicines and Medical Devices Regulation has called for submissions from stakeholders regarding regulation of complementary medicines.

The panel, headed by Emeritus Professor Lloyd Sansom and announced last year (PD 27 Oct 14), released an addendum to its discussion paper today dealing with complementary medicines.

The chapter, which was flagged at the time of the Review’s announcement, asks various questions of stakeholders, including whether an ingredient should only be considered to have been ‘approved’ by an overseas regulator if it had been subjected to assessment, and if so, whether this assessment should include quality, safety and efficacy.

The document said while Canadian regulators undertook pre-market evaluation of ingredients in complementary medicines for quality, safety and efficacy, the US Food and Drug Administration only require notification of a new ingredient and demonstration of a reasonable expectation of safety for use in a dietary supplement.

“As such, ‘approval’ of a new ingredient in Canada means something quite different than ‘approval’ of a new ingredient in the US.

“In Australia, the TGA assesses quality and safety of a new ingredient, but does not undertake an assessment of efficacy.”

Other questions asked of stakeholders include whether Australia should adopt approval of ingredients by ‘trusted’ overseas regulators, whether the current regulatory regime for complementary medicines in Australia is commensurate with the risk posed by products, and whether low-risk complementary medicines should be regulated as general consumer goods, rather than having to be listed on the Australian Register of Therapeutic Goods.

The chapter also asks whether current legislation provided sufficient deterrents to prevent sponsors “knowingly listing non-compliant complementary medicines” on the Register, citing the fact that sponsors could request a product be removed from the Register if it is subjected to a review by the Therapeutic Goods Administration, and re-list it at a later date.

Submissions on the addendum are due by 08 Apr.

For more, see Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Aug

Weekly Comment 21 Aug 17 - WELCOME to PD's weekly comment feature. This ...


21 Aug

Dispensary Corner 21 Aug 17 - THERE'S been a major fake tan fail ...


21 Aug

Healthscope sells medical centres - HEALTHSCOPE Limited on Fri confirmed the $55 ...


21 Aug

Generic orlistat - ARROW Pharma has announced the launch of ...


21 Aug

CW stocks SASMAR - SASMAR has announced that its Conceive Plus ...


21 Aug

Connect with CPD - NEXT week's Pharmacy Connect conference at the ...


21 Aug

JPPR vulnerable focus - THE latest issue of the flagship publication ...


21 Aug

Fake meds webinar - THE International Pharmaceutical Federation (FIP) has announced ...


21 Aug

30% pharmacist pay rise push - PROFESSIONAL Pharmacists Australia has launched a campaign ...


21 Aug

Practice guidelines revised - THE Pharmaceutical Society of Australia (PSA) has ...


18 Aug

Events Calendar 18 Aug 17 - WELCOME to Pharmacy Daily's events calendar, opportunities ...


18 Aug

Dispensary Corner 18 Aug 17 - THE "afterburner effect" is probably a significant ...


18 Aug

Soliris patent extends - ALEXION Pharmaceuticals has announced that the United ...


18 Aug

New US telepharmacy - RETAIL giant Kmart has opened its first ...


18 Aug

Aus/NZ paracetamol poisoning guidelines - UPDATED guidelines around management of paracetamol poisoning ...


18 Aug

UK OTC psoriasis - BRITAIN'S Medicines and Healthcare products Regulatory Agency ...


18 Aug

TGA balances Lateline - THE Therapeutic Goods Administration's (TGA's) Special Access ...


18 Aug

Medicine misuse - NPS MedicineWise's 7th annual campaign has been ...


18 Aug

Course fever runs hot - GUILD Learning and Development has partnered with ...


18 Aug

FDA Zika samples - THE US Food and Drug Administration (FDA) ...



Show Pharmacy Daily items by month: